Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
Ligand Pharmaceuticals (LGND) - Total debt
Total debt on the balance sheet as of December 2023 : $6.16 M
According to Ligand Pharmaceuticals's latest financial reports the company's total debt is $6.16 M. A company’s total debt is the sum of all current and non-current debts.
Ligand Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $6.16 M | -92.97% |
| 2022-12-31 | $87.74 M | -72.95% |
| 2021-12-31 | $0.32 B | -28.93% |
| 2020-12-31 | $0.45 B | -29.8% |
| 2019-12-31 | $0.65 B | 2.18% |
| 2018-12-31 | $0.63 B | 183.39% |
| 2017-12-31 | $0.22 B | 5.46% |
| 2016-12-31 | $0.21 B | 5.41% |
| 2015-12-31 | $0.20 B | 3.1% |
| 2014-12-31 | $0.19 B | 2050.71% |
| 2013-12-31 | $9.1 M | -67.79% |
| 2012-12-31 | $28.27 M | -6.63% |
| 2011-12-31 | $30.28 M | 32.54% |
| 2010-12-31 | $22.85 M | -37% |
| 2009-12-31 | $36.27 M | -29.61% |
| 2008-12-31 | $51.53 M | 2291.23% |
| 2007-12-31 | $2.15 M | -94.88% |
| 2006-12-31 | $42.07 M | -75.67% |
| 2005-12-31 | $0.17 B | -0.63% |
| 2004-12-31 | $0.17 B | 0.86% |
| 2003-12-31 | $0.17 B | 9.66% |
| 2002-12-31 | $0.15 B | 10.7% |
| 2001-12-31 | $0.14 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 475,682.64% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 1,149,048.42% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 409,069.51% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 1,047,961.64% | 🇺🇸 USA |
 Baxter BAX | $14.36 B | 232,892.70% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 568,513.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 931,108.43% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 371,950.28% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $28.84 M | 367.80% | 🇺🇸 USA |